<DOC>
	<DOCNO>NCT02435862</DOCNO>
	<brief_summary>A Phase 2 , Randomized , Double-masked , Placebo-controlled Multicenter Clinical Trial Designed Evaluate Safety Efficacy Luminate Inducing PVD Subjects Non-Proliferative Diabetic Retinopathy .</brief_summary>
	<brief_title>A Clinical Trial Designed Evaluate Safety Efficacy Study LuminateÂ® Inducing PVD ( Posterior Vitreous Detachment ) Non-Proliferative Diabetic Retinopathy</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Vitreous Detachment</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>1 . NonProliferative Diabetic Retinopathy Subjects grade 2 . Subjects either ) PVD , b ) stage 1 PVD c ) stage 2 PVD baseline bscan study eye 3 . Subjects least 45 year age 4 . Subjects free significant retinal pathology could interfere measurement conduct study 5 . Intraocular Pressure control , IOP 30 mm less 6 . Male female subject 7 . Signed Informed Consent 1 . No medium opacity abnormality would preclude observation retina performance study relate image test 2 . History prior vitrectomy study eye 3 . Subjects epiretinal membrane , vitreomacular adhesion , vitreomacular traction , macular hole study eye baseline 4 . Subjects proliferative DR , neovascular AMD , retinal vascular occlusion study eye 5 . Subjects clinically significant macular edema study eye 6 . Subjects history focal/grid panretinal laser photocoagulation study eye 7 . Subjects likely need intraocular surgery , laser treatment , nonstudy intravitreal injection study eye study period . 8 . Subjects history retinal detachment study eye 9 . High myope spherical equivalent &gt; 8.00 D spectacle correction study eye 10 . Subjects systolic BP &gt; 180 screen 11 . Subjects HgA1c &gt; 12.0 within 90 day precede enrollment 12 . Subjects chronic recurrent uveitis 13 . Subjects ongoing ocular infection inflammation 14 . Subjects uncontrolled glaucoma , ie IOP &gt; 25mm without IOP lower agent 15 . Subjects contraindication study medication 16 . Subjects unable meet extensive postop evaluation regimen 17 . Pregnant nursing woman 18 . Subjects history penetrate ocular trauma study eye 19 . Subjects participate another clinical research study</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Vitreolysis Vitreous</keyword>
</DOC>